FEED — ENvue Medical Inc.

ENvue Medical Inc. (FEED) is a medical devices company listed on NASDAQ. It is led by Doron Robert Besser M.D., based in 969 Pruitt Ave, Tyler, TX, United States, 77569, with about 12 employees. ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.

Latest reported FEED revenue for 2026-06-30 was $239.0K. Net income was -$4.9M. Revenue was down 63.4% from 2026-03-31 to 2026-06-30. FEED currently screens at market cap $4.7M.

Use this FEED page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FEED quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FEED SEC filings page. Lician reads the product cache first so this HTML stays unique to ENvue Medical Inc. even when a live quote feed is slow.